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Eleven macroalgae were collected from the KwaZulu-
Natal coast and nineteen species from the cooler
Western Cape coast in March and April 2000. Ethanolic
and aqueous extracts were made and tested for biolog-
ical activity in the Cox-1 anti-inflammatory assay, in a
nematode mortality bioassay for anthelminthic activity,
an IC50 anticancer assay and a MIC antimicrobial assay.
The ethanolic extracts were very active in the Cox-1
anti-inflammatory assay for almost all of the species
tested. The aqueous extracts were not active. No
anthelminthic mortality was detected in extracts from
any of the species tested. Many of the extracts had cyto-
toxic activity against three cancer cell lines tested, with
those from representative species of the Chlorophyta
and Rhodophyta being the most effective. The extracts
had much lower cytotoxic activity when tested on nor-
mal mouse fibroblasts (NIH3T3). Extracts from only a
few species had antimicrobial activity with those of the
Chlorophyta tested being the most effective against
both the Gram-positive and Gram-negative bacteria.
Many drugs used to treat ailments and diseases have
severe side effects especially if used in long term treatment.
Pathogens also develop resistance to drugs. It is thus nec-
essary to constantly improve and develop new drugs. There
is a trend in developed countries towards utilising natural
drugs rather than synthetic drugs. This is not a new concept
with many cultures having a history of traditional medicine.
The World Health Organization (WHO) estimates that
almost 65% of the world’s population has incorporated
herbal remedies into its primary health care (Fabricant and
Farnsworth 2001).
The use of seaweed in traditional medicine is not nearly as
extensive as the use of land plants. There are records in
ancient Chinese medicinal literature of seaweed being used
both as food and medicine prior to 2000BC (Abbott 1996).
Seaweeds are eaten extensively in Asia while algal products
such as agar, alginate and carageenans are widely used in
food products in Western countries (Abbott 1996). Examples
of medicinal use of seaweeds include Sargassum tea to
treat diseases such as goiter and excess phlegm (Yan et al.
1998) and Caulerpa taxifolia used in herbal medicines in the
Philippines as an antifungal and hypertensive agent
(Ninomiya et al. 1998).
Algae are a diverse group of organisms which occupy a
wide variety of ecological niches not occupied by land
plants. Algae are also, evolutionarily-speaking, far older than
land plants which are already known as a rich source of bio-
logically active compounds. Natural products from land
plants have already provided many important leads in phar-
maceutical research (see Fabricant and Farnsworth (2001)
for an extensive list of drugs derived from plants). In many
ways, algae are similar to higher plants in their biochemical
makeup. They also have a number of secondary metabolites
that serve as chemical defence mechanisms against her-
bivory, fouling by epiphytes and larval settlement, and com-
petitors for space (De Nys et al. 1998, De Lara-Isassi et al.
2000). It is thus highly probable that algae have the poten-
tial to provide an alternative source of leads to solving bio-
medical problems (Baker 1984, Bustos et al. 1992, Apt and
Behrens 1999). 
Seaweeds are biologically active in many assays and
some bioactive compounds have been identified. For exam-
ple, algae and Cyanobacteria show antiviral activity towards
the mumps, influenza and the Herpes simplex viruses
(Schaeffer and Krylov 2000, Huleihel et al. 2001). Some
algae have anticoagulant activity (Matsubara et al. 2001),
antifungal activity (Ballesteros et al. 1992) and anti-oxidant
activity (Le Tutour et al. 1998, Yan et al. 1998, Ruberto et al.
2001). Water extracts of Chlorella vulgaris contain a prophy-
lactic agent which controls allergies which are characterised
by the production of allergen specific IgE (Hasegawa et al.
1999).
Introduction
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Antimicrobial activity has been the most widely investi-
gated medicinal property in algae. Antibacterial activity in
algae was first reported in the 1940s in the microalga
Chlorella vulgaris where the fatty acid chlorellin was the
active constituent (Robles Centeno and Ballentine 1999).
There have since been numerous surveys highlighting
algae as potential sources of antimicrobial substances
(Sastry and Rao 1994). Results vary depending on the
bacterial strains tested in conjunction with the solvents
used for extraction. Ethanol is the most commonly used
extracting solvent and is generally the most efffective at
extracting the antibacterial compounds (Vlachos et al.
1996).
Anti-inflammatory activity is fairly well documented in
seaweeds. Payá et al. (1990) and Bustos et al. (1992)
tested seven Mediterranean seaweeds where both polar
and non-polar extracts showed high anti-inflammatory
activity in the Mouse Paw and Mouse Ear Edema assays.
The red alga Vidalia obtusaloba has two bromophenols
with anti-inflammatory activity, which are thought to be
related to defence against marine herbivores (Wiemer et
al. 1991). The brown alga Caulocystis cephalornithos has
anti-inflammatory activity with the active principal identi-
fied as the trisubstituted aromatic ring 6-tridecylsalicylic
acid (Kazlauskas et al. 1980). Caulerpa taxifolia is able to
inhibit the lipooxygenase pathway and the active com-
pound is a derivative of caulerpenyne (Ninomiya et al.
1998). Oxylipins are important in the treatment of many
inflammatory diseases, heart diseases and ulcers and
they have been found in many algal species from all the
major taxonomic divisions. These show strong potential
for development as new pharmaceutical agents or phar-
macological probes (Gerwick et al. 1991). A few South
African seaweeds have previously been screened using
the Cox-1 inflammatory assay where almost all the
ethanolic extracts were inhibitory and the aqueous
extracts showed very little inhibitory activity (Stirk et al.
1996).
As with higher plants, the progress of developing marine
natural products for pharmacological use proceeds in two
ways. Firstly, there is the screening of crude extracts to
identify sources of potentially important compounds. This
screening must be for a diverse range of assays and
should also determine seasonal and geographical varia-
tion. Secondly, one needs to isolate and identify the active
principal and study its pharmacological properties (De
Freitas 1990). Although a number of novel bioactive com-
pounds have been identified in algae, none have been
developed into commercial pharmaceutical products. The
probability of developing a commercial product is directly
correlated with the amount of screening and there has
been considerably less attention focussed on the algae
than on higher land plants (Apt and Behrens 1999).
The aim of this work was to screen some crude extracts
of common South African macroalgae in a number of
assays to determine their potential medicinal value and to
indicate areas where more intensive screening should be
conducted. The biological activities tested were the Cox-1
anti-inflammatory, anthelminthic, antifungal, anticancer
and antimicrobial activity.
Material and Methods
The seaweeds were collected from Rocky Bay on the
KwaZulu-Natal coast (30°23’S, 30°43’E) in March 2000 and
from Kommetjie on the Western Cape coast (34°08’S,
18°43’E), South Africa in April 2000. The KwaZulu-Natal
coast is subtropical where temperatures seldom drop below
20°C while the Western Cape coast is a cool temperate
region affected by upwelling where the temperatures vary
between 8–16°C and the waters are nutrient rich (Branch
and Branch 1985). Seaweeds were transported to the labo-
ratory in a cooler box where they were immediately identi-
fied, washed and epiphytes removed before being air-dried
in front of a fan at room temperature. The dried seaweed
was stored for up to one year at 10°C until needed.
The dried material was ground to a fine powder using liq-
uid nitrogen. Ethanolic (100% ethanol) and aqueous (dis-
tilled water) extracts were prepared by adding 20ml of the
solvent to 2g of the dried seaweed powder. The extracts
were sonicated in an ultrasound bath for 30min and left to
stand overnight at 10°C after which they were sonicated for
a further 15min. The extracts were filtered under vacuum
through Whatman No. 1 filter paper and then dried down in
a stream of air. The resulting extract weights were recorded
and the extracts stored at 10°C until needed. These extracts
were used in the anti-inflammatory and anthelminthic
assays.
For the antimicrobial and anticancer assays, 0.5–1g of the
original dried material was extracted with 30ml 100%
ethanol for 2h. After centrifugation at 15 000rpm at 4°C for
15min, the pellet was re-extracted using the same method.
Both extracts were combined and purified using a C18 col-
umn to remove the chlorophyll and then dried at 35°C under
vacuum. The dried extracts were dissolved in 200µl 50%
methanol and 800µl 0.1M Tris.HCl (pH 7.5), filter sterilised
using a 0.2µm filter and used in the antimicrobial and anti-
cancer assays.
Cyclooxygenase-1 (Cox-1) assay for anti-inflammatory
activity
The Cox-1 assay was performed according to the method of
White and Glassman (1974) with modifications by Jäger et
al. (1996) to test for anti-inflammatory activity where inhibi-
tion refers to the reduction of prostaglandin formation in
comparison to an untreated control. Indomethacin was used
as a positive control. Ethanolic and aqueous extracts (as
described above) of the Cape algae were screened. The
residue of the ethanolic extracts were resuspended in
ethanol at 10mg ml–1 and the residue of the aqueous
extracts were resuspended in distilled water at 2.5mg ml–1 to
give the final test concentration of the extract as 250µg ml–1
and 500µg ml–1 for the ethanolic and aqueous extracts
respectively. All samples were tested in duplicate in the
assay to ensure accurate assay results. The means were
determined and presented as percentage inhibition. This
was calculated using the 14C conversion for solvent blanks
and untreated controls where no inhibitory compounds were
added which gave the maximum conversion of arachidonic
acid to prostaglandins in the assay conditions used.
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Nematode mortality assay for anthelminthic activity
Caenorhabditis elegans var. Bristol (N2) nematodes were
cultured on nematode growth agar seeded with E. coli fol-
lowing the method of Brenner (1974). A simple nematode
mortality bioassay described by Rasoanaivo and
Ratsimamanga-Urveg (1993) and modified by McGaw et al.
(2000) was used to screen the aqueous extracts of the Cape
algae. Algal extracts were resuspended at 50mg ml–1 in dis-
tilled water and added to the sterile repli-dishes to give a
final test concentration of 1mg ml–1. These nematode cul-
tures were incubated for 2h at 25°C in the dark. Nematode
mortality was measured by comparing the movement, using
a dissecting microscope, of the nematodes in the test
extracts to those in the control and expressed as a percent-
age. The drug levamisole was used as an internal standard
at the concentration 5µg ml–1. The experiment was repeated
twice.
Anticancer IC50 assay
Both Cape and KwaZulu-Natal macroalgae were screened
for activity. This bioassay used cell lines of different histoge-
netic and species origin: the panel of cell lines used was the
MCF7 (human breast adenocarcinoma), CEM (human lym-
phoblastoid leukaemia) and G361 (human malignant
melanoma) cancer cell lines, with the NIH3T3 (mouse
fibroblasts) as a normal cell line. The cell lines were grown
in DMEM medium (Gibco BRL) supplemented with 10%
(v/v) foetal bovine serum and L-glutamine and maintained at
37°C in a humidified atmosphere with 5% CO2. Each well of
a 96 well plate was seeded with 104 cells, allowed to sta-
bilise for at least 4h, after which 20µl of the algal test
extracts was added at six concentrations ranging from 0.5–
0.005g ml–1. These assays were repeated on three occa-
sions. The plates were incubated at 37°C and 5% CO2 for
three days after which Calcein AM solution (Molecular
Probes) was added. After 1h, the fluorescence of the viable
cells was quantified using Fluoroscan Ascent
(Microsystems). The IC50 value, the extract concentration
lethal to 50% of the tumour cells, was calculated from the
dose response curve.
Antimicrobial MIC assay
Ethanolic extracts of Cape and KwaZulu-Natal algae were
screened in this bioassay using the Gram-postive bacteria
strains Enterococcus faecalis 4224, Staphylococcus aureus
3953 and 4223 and the Gram-negative bacteria
Pseudomonas aeruginosa 3955 and Escherichia coli 3954,
3988 and 4225 (Czech Collection of Microorganisms, Brno).
Bacteria were precultured for 2h at 37°C in 5ml Mueller-
Hinton Broth and then diluted with distilled water in a 1:10
ratio and inoculated into the sterile wells containing the algal
extract in the cultivation medium. The dried ethanolic
extracts of the tested algae were resuspended in distilled
water (1g ml–1). The cultivating medium for Gram-positive
bacteria contained 37g Brian Heart Infusion in 1l distilled
water. The cultivating medium for Gram-negative bacteria
consisted of 5g Protose-BE, 17.5g Casein Acid Hydrolysate
and 0.06g Na2CO3 in 1l distilled water. Wells of microtiter
plates containing serial two-fold dilutions of the extracts
were inoculated with the bacteria inoculum and incubated
for 18h at 37°C. The wells were then examined for the pres-
ence of bacterial growth. The lowest concentration of each
extract dilution series that prevented bacterial growth was
considered to be the minimum inhibitory concentration (MIC)
of the extract. There were three replicates per assay and
each assay was repeated twice.
Results
Cox-1 assay for anti-inflammatory activity
The ethanolic extracts from most of the species tested were
highly inhibitory in the Cox-1 assay with eleven of the twelve
species having similar or higher inhibition than that of the
indomethacin standard (72% inhibition, Table 1). All of the
water extracts showed less inhibition than that of the
indomethacin standard (71% inhibition, Table 1). It was not
possible to make water extracts for all the seaweeds as
many formed a polysaccharide gel, such as alginate, when
exposed to water.
Nematode mortality assay for anthelminthic activity
The levamisole internal standard showed 100% mortality
and the water control showed 100% nematode survival after
2h incubation. In all the algal test extracts, there was 100%
nematode survival indicating no anthelminthic activity in the
aqueous extracts of the Cape algae.
Table 1: Cox-1 inhibitory activity of ethanol and water extracts of the
Cape macroalgae. The final test concentration of the extracts was
250µg ml–1 for the ethanolic extract and 500µg ml–1 for the aqueous
extract. nt = not tested
Species Inhibition (%)
Ethanolic extract Aqueous extract
Indomethacin (20µM) 72 71
Chlorophyta
Cladophora capensis 91 56
Ulva sp. 76 nt
Phaeophyta
Bifurcaria brassicaeformis 78 55
Ecklonia maxima 97 68
Laminaria pallida nt 49
Macrocystis angustifolia 78 48
Sarcothalia stiriata (gametophyte) 83 nt
Sarcothalia stiriata (sporophyte) 79 nt
Rhodophyta
Hypnea spicifera 5 50
Mazzaella capensis 71 nt
Carradoriella virgata 90 nt
Porphyra capensis 95 nt
Suhria vittata 80 nt
Aeodes orbitosa nt 43
Hymenena venosa nt 53
Anticancer IC50 assay
The algal extracts were active against all of the three cancer
cell lines tested. Higher effectiveness of the algal extracts was
found when tested on the cell lines bearing various mutations
or deletions in the cell-cycle-associated proteins e.g. CEM cell
line. This indicates that these extracts should be effective in
tumours with various alterations of tumour suppressor genes
such as p53 and pRb. Growth of the normal mouse fibroblasts
was also affected but only when subjected to concentrations
at least 10 times higher than those experienced by the cancer
lines. Generally the Phaeophyta were the least effective with
high concentrations of extract required to obtain IC50. The
Chlorophyta tested showed the most biological activity
against the CEM cell line, with very low concentrations of
Caulerpa filiformis and Halimeda cuneata extracts needed to
obtain IC50. These chlorophyte extracts also effectively inhibit-
ed growth in the other three cancer cell lines. The Rhodophyta
tested were generally able to inhibit all the cancer cell lines at
low extract concentrations with the KwaZulu-Natal algae
Amphiroa ephedraea, Arthrocardia sp. and Corallina sp. (all
Corallinaceae) and the Cape Gigartina clathrata, G. polycarpa
and Sarcothalia scutellata (all Gigartinaceae) showing the
most effective biological activity (Table 2). 
Antimicrobial MIC assay
Extracts from the chlorophytes tested had the most biologi-
cal activity, with those from Caulerpa filiformis and Halimeda
cuneata inhibiting both Gram-positive and Gram-negative
bacteria. None of those from the Phaeophyta tested inhibit-
ed bacterial growth and only three extracts of the
Rhodophyta tested, Arthrocardia sp., Hypnea spicifera and
Suhria vittata, were able to inhibit Gram-positive bacteria
(Table 3).
Discussion
As in previous Cox-1 anti-inflammatory screenings of South
African seaweeds (Stirk et al. 1996), the aqueous extracts
had low inhibitory activity and the ethanolic extracts were
highly active for most of the seaweed extracts. The ethano-
lic extracts were tested at a lower concentration than that of
the previous screening study (250µg ml–1 as opposed to the
earlier 500µg ml–1), suggesting that the active compound(s)
is/are very effective. Seasonal variation in biological activity
is known to occur in some seaweed species. For example,
of the five South African seaweed species tested for sea-
sonal variation in antimicrobial activity, only one species,
Table 2: IC50 inhibitory concentrations (mg well–1) of the Cape (C) and KwaZulu-Natal (KZN) macroalgae tested against cancer cell lines.
n = 3
Species Province of origin Cancer cell lines Normal cell lines
MCF7 CEM G361 NIH3T3
Chlorophyta
Caulerpa filiformis KZN 0.50 ± 0.10 0.004 ± 0.0005 0.47 ± 0.12 1.02 ± 0.21
Halimeda cuneata KZN >0.20 0.007 ± 0.0003 0.13 ± 0.02 0.43 ± 0.10
Ulva sp. KZN 0.40 ± 0.08 0.13 ± 0.02 1.38 ± 0.14 1.55 ± 0.21
Cladophora capensis C 1.80 ± 0.25 1.00 ± 0.18 >2.0 >2.0
Ulva sp. C 2.10 ± 0.35 0.94 ± 0.11 >2.0 >2.0
Phaeophyta
Sargassum heterophyllum KZN 1.40 ± 0.26 0.11 ± 0.02 1.62 ± 0.19 1.85 ± 0.24
Bifurcaria brassicaeformis C >2.0 >2.0 >2.0 >2.0
Splachnidium rugosum C 3.40 ± 0.80 1.00 ± 0.24 >2.0 >2.0
Laminaria pallida C >5.0 1.40 ± 0.26 >2.0 >2.0
Macrocystis angustifolia C 1.00 ± 0.21 0.33 ± 0.07 1.75 ± 0.32 >2.0
Rhodophyta
Amphiroa bowerbankii KZN 8.20 ± 2.70 0.06 ± 0.015 1.03 ± 0.18 1.28 ± 0.23
Amphiroa ephedraea KZN 0.06 ± 0.009 0.04 ± 0.006 0.95 ± 0.18 1.06 ± 0.25
Arthrocardia sp. KZN 0.03 ± 0.005 0.03 ± 0.007 0.78 ± 0.16 0.95 ± 0.21
Cheilosporum sp. KZN 1.10 ± 0.29 <0.02 0.12 ± 0.02 0.45 ± 0.09
Corallina sp. KZN 0.03 ± 0.004 0.03 ± 0.005 0.39 ± 0.06 0.67 ± 0.12
Jania sp. KZN 1.30 ± 0.21 0.01 ± 0.002 0.12 ± 0.02 0.35 ± 0.06
Aeodes orbitosa C 0.90 ± 0.21 0.08 ± 0.005 1.12 ± 0.21 1.15 ± 0.23
Gigartina clathrata C 0.07 ± 0.012 0.06 ± 0.009 0.68 ± 0.14 0.65 ± 0.10
Gigartina polycarpa C 0.09 ± 0.01 0.05 ± 0.008 0.53 ± 0.12 0.74 ± 0.22
Sarcothalia scutellata C 0.10 ± 0.02 0.07 ± 0.014 0.14 ± 0.09 0.32 ± 0.10
Hymenena venosa C 0.28 ± 0.09 0.09 ± 0.02 0.29 ± 0.08 0.54 ± 0.12
Hypnea spicifera C 0.46 ± 0.11 0.16 ± 0.08 0.92 ± 0.32 1.23 ± 0.28
Mazzaella capensis C 2.20 ± 0.34 0.06 ± 0.02 0.18 ± 0.05 0.45 ± 0.11
Nothogenia erinacea C 0.12 ± 0.02 0.05 ± 0.008 0.34 ± 0.08 0.52 ± 0.13
Plocamium corallorhiza C 1.14 ± 0.25 0.26 ± 0.09 0.91 ± 0.18 1.25 ± 0.24
Carradoriella virgata C 1.56 ± 0.35 0.49 ± 0.12 1.32 ± 0.26 1.54 ± 0.32
Porphyra capensis C 0.38 ± 0.11 0.18 ± 0.05 0.63 ± 0.12 0.85 ± 0.14
Sarcothalia stiriata C 0.24 ± 0.06 0.04 ± 0.002 0.31 ± 0.07 0.56 ± 0.12
Suhria vittata C 0.46 ± 0.15 0.16 ± 0.05 0.85 ± 0.21 1.18 ± 0.35
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Osmundaria serrata (Rhodophyta), showed increased activ-
ity in material collected during winter (Vlachos et al. 2001).
Fourteen species collected from the coast of India all had
increased antibacterial activity after the monsoon season
(Vidyavathi and Sridhar 1991). A comparison of the Cox-1
anti-inflammatory activity from summer (1994; Stirk et al.
1996) and autumn (2000; current study) extracts suggests
that these active principals are not greatly influenced by sea-
son.
There is ethnopharmacological evidence that seaweeds
contain active anthelminthic compounds. In China, children
infected with intestinal worms are treated with the seaweeds
Digenea simplex and Caloglossa leprieurii, both of which
contain the anthelminthic kainic acid, and Chondria species,
where the active principal is domoic acid (Tseng 2001). Only
the water extracts of the Cape algae were tested in the cur-
rent screening study as McGaw et al. (2000) showed that, in
higher land plants, the water extracts show more inhibitory
activity than ethanol extracts. None of the macroalgae test-
ed were able to kill the nematodes. However, other side
effects, such those on the reproductive potential, were not
considered.
The results obtained from the anticancer assay were par-
ticularly promising with many of the species tested being
cytotoxic to the different histogenetic cancer cell lines. On
the other hand, cytotoxicity of the algal ethanolic extracts for
normal mouse fibroblasts was more than 10x lower. Further
studies are needed in this respect. There are also some
other studies confirming that algal extracts are cytotoxic.
Ballesteros et al. (1992) found that 35% of the 71 seaweeds
tested using kidney cells of monkey were cytotoxic, with
over half of the chlorophytes tested being cytotoxic.
Chlorella vulgaris extracts administered orally to tumour-
bearing mice significantly prolonged their survival by
enhancing phagocyte production and quality (Justo et al.
2001). Caulerpenyne from Caulerpa taxifolia is also cytotox-
ic and inhibits growth in human cancer cell lines by modify-
ing the microtubule network (Barbier et al. 2001).
Ballesteros et al. (1992) found only 6% of the 71
Mediterranean seaweeds tested had antibacterial activity.
Similarly, only a few of the macroalgae tested in this study
had antimicrobial activity with 23% of the 30 species tested
being active. The Chlorophyta predominated, with four of the
five species tested being active against both Gram-positive
and Gram-negative bacteria. The Rhodophyta tested
showed limited antibacterial activity while none of the
Table 3: Antimicrobial activity (MIC) of extracts of Cape (C) and KwaZulu-Natal (KZN) macroalgae. Sa = Staphylococcus aurens, Ef =
Enterococcus faecalis, Ec = Escherichia coli, Pa = Pseudomonas aeruginosa. Bold figures highlight the most active extracts
Species Province of origin Minimal Inhibitory Concentration (mg ml–1)
Gram-positive bacteria Gram-negative bacteria
Sa3953 Sa4223 Ef4224 Ec4225 Ec3988 Ec3954 Pa3955
Chlorophyta
Caulerpa filiformis KZN 0.0065 0.0065 0.0325 0.0325 0.065 >0.0325 0.0065
Halimeda cuneata KZN 0.025 0.025 0.025 0.025 0.013 0.025 0.025
Ulva sp. KZN >0.15 >0.15 >0.15 0.15 0.075 0.15 0.075
Cladophora capensis C 0.0625 0.0625 0.125 >0.25 0.125 >0.25 >0.25
Ulva sp. C >0.25 >0.25 >0.25 0.25 0.125 0.25 0.125
Phaeophyta
Sargassum heterophyllum KZN >0.175 >0.175 >0.175 >0.175 >0.175 >0.175 >0.175
Bifurcaria brassicaeformis C >0.25 >0.25 >0.25 >0.25 >0.25 >0.25 >0.25
Splachnidium rugosum C >0.25 >0.25 >0.25 >0.25 >0.25 >0.25 >0.25
Laminaria pallida C >0.25 >0.25 >0.25 >0.25 >0.25 >0.25 >0.25
Macrocystis angustifolia C 0.25 0.25 >0.25 >0.25 0.25 0.25 >0.25
Rhodophyta
Amphiroa bowerbankii KZN 0.25 0.25 >0.25 >0.25 >0.25 >0.25 >0.25
Amphiroa ephedraea KZN >0.22 >0.22 >0.22 >0.22 >0.22 >0.22 >0.22
Arthrocardia sp. KZN 0.13 0.065 >0.13 >0.13 >0.13 >0.13 >0.13
Cheilosporum sp. KZN 0.12 0.12 >0.12 >0.12 >0.12 >0.12 >0.12
Corallina sp. KZN 0.1375 >0.1375 >0.1375 >0.1375 >0.1375 >0.1375 >0.1375
Jania sp. KZN 0.1425 >0.1425 >0.1425 >0.1425 >0.1425 >0.1425 >0.1425
Aeodes orbitosa C >0.25 >0.25 >0.25 >0.25 >0.25 >0.25 >0.25
Gigartina clathrata C >0.25 >0.25 >0.25 >0.25 >0.25 >0.25 >0.25
Gigartina polycarpa C 0.25 >0.25 >0.25 >0.25 >0.25 >0.25 >0.25
Sarcothalia scutellata C >0.22 >0.22 >0.22 >0.22 >0.22 >0.22 >0.22
Hymenena venosa C >0.25 >0.25 >0.25 0.125 0.125 0.25 0.25
Hypnea spicifera C 0.0425 0.0425 0.0425 >0.17 0.17 >0.17 0.17
Mazzaella capensis C >0.25 0.25 >0.25 >0.25 >0.25 >0.25 >0.25
Nothogenia erinacea C >0.25 >0.25 >0.25 >0.25 >0.25 >0.25 >0.25
Plocamium corallorhiza C 0.25 0.25 0.25 0.25 0.25 0.25 0.25
Carradoriella virgata C 0.125 0.125 >0.25 >0.25 >0.25 >0.25 >0.25
Porphyra capensis C 0.1475 0.1475 >0.1475 >0.1475 0.1475 >0.1475 >0.1475
Sarcothalia stiriata C >0.25 >0.25 >0.25 >0.25 >0.25 >0.25 >0.25
Suhria vittata C 0.0625 0.0625 0.0625 >0.25 >0.25 >0.25 0.25
Phaeophyta tested showed antibacterial activity. Particularly
promising is that the chlorophyte species tested were effec-
tive against the Gram-negative bacterial strains. Many
antibiotics are less active against Gram-negative than
Gram-positive bacteria, probably as a result of the more
complex cell wall structure with additional lipopolysaccha-
rides on the outer surface of the Gram-negative bacteria
which makes penetration of the extracts more problematic
(Rang and Dale 1987).
Previously, Vlachos et al. (1997) screened 56 South
African seaweeds for antimicrobial activity using an agar-
overlay diffusion method. Unlike the present study, the
authors found that the Phaeophyta they tested were the
most effective antimicrobial agents, mainly against Gram-
positive and a few Gram-negative bacterial strains, while the
Rhodophyta and Chlorophyta investigated showed limited
inhibitory activity against the Gram-positive bacterial strains
tested (Vlachos et al. 1997, 1999). However, they used dif-
ferent extraction methods, boiling the extracts which could
have denatured heat sensitive compounds (Vlachos et al.
1997). This extraction method was established in a previous
comparative study (Vlachos et al. 1996) designed to opti-
mise the protocol for testing antimicrobial activity in sea-
weeds and testing different bacterial strains. Vlachos et al.
(1997) also did not mention the concentration of the sea-
weed extracts tested so comparisons between bioassays or
species cannot be made. The agar diffusion method used by
Vlachos et al. (1997) relies on the size, diffusibility and
chemical properties (eg. hydrophobicity) of the inhibitory
compound/s which could influence the results.
Before specific algae can be chosen for the isolation and
identification of the active compounds, seasonal and geo-
graphic variation also needs to be considered. The com-
parison of the results from the Cox-1 anti-inflammatory
assay in this study and from Stirk et al. (1996) indicates that
the active anti-inflammatory compounds are not sensitive to
seasonal changes. However, this is not necessarily true for
all biologically active compounds. Robles Centeno and
Ballentine (1999) grew male and female gametophytes and
tetrasporophytes of the red alga Spyridia filamentosa over
a range of irradiance conditions and then tested the
extracts against five microorganisms for antibiotic activity.
Even small changes in irradiance conditions resulted in dif-
ferent activities and the degree of activity for the various
extracts. The various gametophyte and tetrasporophyte cul-
tures also showed different biological activity. This shows
that there are optimal conditions for the synthesis of sec-
ondary compounds. Thus, screening studies based on a
single collection probably underestimate potential biological
activity. This emphasises the need for many such screening
studies to be undertaken using different bioassays so that
seasonal and geographical assessment of biological activi-
ty can be made.
This study has shown that seaweeds are biologically
active in many assays and that they do contain many sec-
ondary metabolites which can potentially be utilised for phar-
maceutical research. Future work needs to use a wider vari-
ety of assays before the full potential of seaweeds as phar-
maceutical agents can be realised. The areas highlighted in
this study with the most potential are anti-inflammatory, cyto-
toxic and antimicrobial biological activity. Of the organisms
currently tested, those belonging to the Chlorophyta gener-
ally produced the most effective inhibitors and those belong-
ing to the Phaeophyta had the least biological activity.
Acknowledgements — Mr Gavin Maneveldt of the University of the
Western Cape, South Africa, is thanked for collecting the Cape sea-
weeds. This work was supported by the International Foundation for
Science (IFS) in Stockholm Sweden, the Grant Agency of the Czech
Republic No. 522/03/0323, the National Research Foundation,
Pretoria and the University of Natal Research Fund.
References
Abbott IA (1996) Ethnobotany of seaweeds: clues to uses of sea-
weeds. Hydrobiologia 326/327: 15–20
Apt KE, Behrens PW (1999) Commercial developments in microal-
gal biotechnology. Journal of Phycology 35: 215–226
Baker JT (1984) Modern drug research: The potential and problems
of marine natural products. In: Krogsgaard-Larsen P, Christensen
SB, Munksgaard HK (eds) Natural Products and Drug
Development. Alfred Benzon Symposium 20, Copenhagen, pp
145–163
Ballesteros E, Martin D, Uriz MJ (1992) Biological activity of extracts
from some Mediterranean macrophytes. Botanica Marina 35:
481–485
Barbier P, Guise S, Huitorel P, Amade P, Pesando D, Briand C,
Peyrot V (2001) Caulerpenyne from Caulerpa taxifolia has an
antiproliferative activity on tumor cell line SK-N-SH and modifies
the microtubule network. Life Sciences 70: 415–429
Branch G, Branch M (1985) The Living Shores of Southern Africa.
C. Struik Publishers, Cape Town, pp 13–20. ISBN
0–86977–115–9
Brenner S (1974) The genetics of Caenorhadbitis elegans. Genetics
77: 71–94
Bustos G, Ferrándiz ML, Sanz MJ, Blasco R, Payá M, Boisset F,
Alcaraz MJ (1992) Topical anti-inflammatory activity of some
Mediterranean marine species. Planta Medica 58: 483
De Freitas JC (1990) Biomedical importance of marine natural prod-
ucts. Ciência e Cultura 42: 20–24
De Lara-Isassi G, Álvarez-Hernández S, Collado-Vides L (2000)
Ichtyotoxic activity of extracts from Mexico marine macroalgae.
Journal of Applied Phycology 12: 45–52
De Nys R, Dworjanyn SA, Steinberg PD (1998) A new method for
determining surface concentrations of marine natural products on
seaweeds. Marine Ecological Progress Series 162: 79–87
Fabricant DS, Farnsworth NR (2001) The value of plants used in tra-
ditional medicine for drug discovery. Environmental Health
Perspectives 109 Supplement: 69–75
Gerwick WH, Bernart MW, Jiang ZD, Moghaddam MF, Nagle DG,
Proteau PJ, Wise ML, Hamberg M (1991) Patterns of oxylipin
metabolism in marine organisms. Second International Marine
Biotechnology Conference, Baltimore, USA, pp 369–378
Hasegawa T, Ito K, Ueno S, Kumamoto S, Ando Y, Yamada A,
Nomoto K, Yoshikai Y (1999) Oral administration of hot water
extracts of Chlorella vulgaris reduces IgE production against milk
casein in mice. International Journal of Immunopharmacology 21:
311–323
Huleihel M, Ishanu V, Tal J, Arad S (2001) Antiviral effect of red
microalgal polysaccharides on Herpes simplex and Varicella
zoster viruses. Journal of Applied Phycology 13: 127–134
Jäger AK, Hutchings A, Van Staden J (1996) Screening of Zulu
medicinal plants for prostaglandin-synthesis inhibitors. Journal of
Ethnopharmacology 52: 95–111
Justo GZ, Silva MR, Queiroz MLS (2001) Effects of the green algae
Chlorella vulgaris on the response of the host hematopoietic sys-
South African Journal of Botany 2003, 69: 462–468 467
Stirk, Schwalb, Light, Medková, Lenobel, Strnad and Van Staden468
tem to intraperitoneal ehrlich ascites tumor transplantation in
mice. Immunopharmacology and Immunotoxicology 23: 119–131
Kazlauskas R, Mulder J, Murphy PT, Wells RJ (1980) New metabo-
lites from the brown alga Caulocystis cephalornithos. Australian
Journal of Chemistry 33: 2097–2101
Le Tutour B, Benslimane F, Gouleau MP, Gouygou JP, Saadan B,
Quemeneur F (1998) Antioxidant and pro-oxidant activities of the
brown algae, Laminaria digitata, Himanthalia elongata, Fucus
vesiculosus, Fucus serratus and Ascophyllum nodosum. Journal
of Applied Phycology 10: 121–129
Matsubara K, Matsuura Y, Bacic A, Liao M-L, Hori K, Miyazawa K
(2001) Anticoagulant properties of a sulfated galactan preparation
from a marine green alga, Codium cylindricum. International
Journal of Biological Macromolecules 28: 395–399
McGaw LJ, Jäger AK, Van Staden J (2000) Antibacterial,
anthelminthic and anti-amoebic activity in South African medicinal
plants. Journal of Ethnopharmacology 72: 247–263
Ninomiya M, Onishi J-I, Kusumi T (1998) 12-Lipoxygenase inhibito-
ry activity of Japanese seaweeds and isolation of a caulerpenyne
derivative from the green alga Caulerpa taxifolia as an inhibitor.
Fisheries Science 64: 346–347
Payá M, Blasco R, Rios JL, Alcaraz MJ (1990) Anti-inflammatory
screening of some Mediterranean marine species. Planta Medica
56: 660
Rang HP, Dale MM (1987) Pharmacology. Churchill Livingstone,
Edinburgh
Rasoanaivo P, Ratsimamanga-Urverg S (1993) Biological evalua-
tion of plants with reference to the Malagasy flora. Monograph for
the IFS–NAPRECA Workshop on Bioassays. Antanavivo,
Madagascar, pp 9–43
Robles Centeno P, Ballentine DL (1999) Effects of culture conditions
on production of antibiotically active metabolites by the marine
alga Spyridia filamentosa (Ceramiaceae, Rhodophyta). I. Light.
Journal of Applied Phycology 11: 217–224
Ruberto G, Baratta MT, Biondi DM, Amico V (2001) Antioxidant
activity of extracts of the marine algal genus Cystoseira in a
micellar model system. Journal of Applied Phycology 13:
403–407
Sastry VMVS, Rao GRK (1994) Antibacterial substances from
marine algae: Successive extraction using benzene, chloroform
and methanol. Botanica Marina 37: 357–360
Schaeffer DJ, Krylov VS (2000) Anti-HIV activity of extracts and
compounds from algae and cyanobacteria. Ecotoxicology and
Environmental Safety 45: 208–227
Stirk WA, Jäger AK, Van Staden J (1996) Screening of some South
African seaweeds for prostaglandin-synthesis inhibitors. South
African Journal of Botany 62: 108–110
Tseng CK (2001) Algal biotechnology industries and research activ-
ities in China. Journal of Applied Phycology 13: 375–380
Vidyavathi N, Sridhar KR (1991) Seasonal and geographical varia-
tions in the antimicrobial activity of seaweeds from the Mangalore
Coast of India. Botanica Marina 34: 279–284
Vlachos V, Critchley AT, Von Holy A (1996) Establishment of a pro-
tocol for testing antimicrobial activity in southern African macroal-
gae. Microbios 88: 115–123
Vlachos V, Critchley AT, Von Holy A (1997) Antimicrobial activity of
extracts from selected southern African marine macroalgae.
South African Journal of Science 93: 328–332
Vlachos V, Critchley AT, Von Holy A (1999) Differential antibacterial
activity from selected southern African macroalgal thalli. Botanica
Marina 42: 165–173
Vlachos V, Critchley AT, Von Holy A (2001) Effect of post-collection
storage time and season on the antibacterial activity of selected
southern African marine macroalgae. In: Chen F, Jiang Y (eds)
Alga and their Biotechnological Potential. Kluwer Academic
Publishers, The Netherlands, pp 207–213
White RJ, Glassman AT (1974) A simple radiochemical assay for
prostaglandin synthetase. Prostaglandins 7: 123–129
Wiemer DF, Idler DD, Fenical W (1991) Vidalols A and B, new anti-
inflammatory bromophenols from the Caribbean marine red alga
Vidalia obtusaloba. Experientia 47: 851–853
Yan X, Nagata T, Fan X (1998) Antioxidative activities in some
common seaweeds. Plant Foods for Human Nutrition 52:
253–262
Edited by SD Sym
